In 2007, after an independent report described PALB2 as a BRCA2 binding partner [115], targeted sequencing of PALB2 as a new candidate gene for hereditary BC in Finnish HBC families determined a statistical association with one of the identified loss-of-function variants in this gene [54]. This evidence concerns the gene BRCA2 and breast cancer.